1. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021; 42: 3427-520.
2.
Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008; 20: 86-100.
3.
Bongiorni MG, Kennergren C, Butter C, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J 2017; 38: 2995-3005.
4.
Zucchelli G, Di Cori A, Segreti L, et al. Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry. Europace 2019; 21: 771-80.
5.
Steckiewicz R, Świętoń EB, Kołodzińska A, et al. Morphometric parameters of cardiac implantable electronic device (CIED) pocket walls observed on device replacement. Folia Morphol (Warsz) 2017; 76: 675-81.
6.
Knorr D, Bandorski D, Bogossian H, et al. Cephalic vein cutdown is superior to subclavian puncture as venous access for patients with cardiac implantable devices after long-term follow-up. J Clin Med 2024; 13: 1044.
7.
Abu-El-Haija B, Bhave PD, Campbell DN, et al. Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients. J Am Heart Assoc 2015; 4: e001878.
8.
van Rooden CJ, Molhoek SG, Rosendaal FR, et al. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 2004; 15: 1258-62.
9.
Bulur S, Vural A, Yazici M, et al. Incidence and predictors of subclavian vein obstruction following biventricular device implantation. J Interv Card Electrophysiol 2010; 29: 199-202.
10.
Bracke F, Meijer A, Van Gelder B. Venous occlusion of the access vein in patients referred for lead extraction: influence of patient and lead characteristics. Pacing Clin Electrophysiol 2003; 26: 1649-52.
11.
Li X, Ze F, Wang L, et al. Prevalence of venous occlusion in patients referred for lead extraction: implications for tool selection. Europace 2014; 16: 1795-9.
12.
Lickfett L, Bitzen A, Arepally A, et al. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 2004; 6: 25-31.
13.
Stoney WS, Addlestone RB, Alford WC Jr, et al. The incidence of venous thrombosis following long-term transvenous pacing. Ann Thorac Surg 1976; 22: 166-70.
14.
Sticherling C, Chough SP, Baker RL, et al. Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am Heart J 2001; 141: 813-6.
15.
Goto Y, Abe T, Sekine S, Sakurada T. Long-term thrombosis after transvenous permanent pacemaker implantation. Pacing Clin Electrophysiol 1998; 21: 1192-5.
16.
Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol 2002; 25: 1605-11.
17.
Da Costa SS, Scalabrini Neto A, Costa R, et al. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysiol 2002; 25: 1301-6.
18.
Antonelli D, Turgeman Y, Kaveh Z, et al. Short-term thrombosis after transvenous permanent pacemaker insertion. Pacing Clin Electrophysiol 1989; 12: 280-2.
19.
Jastrzębski M, Moskal P, Huybrechts W, et al. Left bundle branch-optimized cardiac resynchronization therapy (LOT-CRT): results from an international LBBAP collaborative study group. Heart Rhythm 2022; 19: 13-21.